Conjugated Linoleic Acid (CLA) Inhibits Expression of the Spot 14 (THRSP) and Fatty Acid Synthase Genes and Impairs the Growth of Human Breast Cancer and Liposarcoma Cells

Overview

Journal Nutr Cancer

Publisher Routledge

Specialties Nutritional Sciences
Oncology

Date 2009 Jan 1

PMID 19116881

Citations 20

Authors

Christina Donnelly

Arne M Olsen

Lionel D Lewis

Burton L Eisenberg

Alan Eastman

William B Kinlaw

Affiliations

Soon will be listed here.

Abstract

Spot 14 (THRSP, S14) is a nuclear protein involved in the regulation of genes required for fatty acid synthesis in normal and malignant mammary epithelial and adipose cells. Harvatine and Bauman (1) reported that conjugated linoleic acid (CLA) inhibits S14 gene expression in bovine mammary and mouse adipose tissues and reduces milk fat production in cows. We hypothesized that CLA inhibits S14 gene expression in human breast cancer and liposarcoma cells and that this will retard their growth. Exposure of T47D breast cancer cells to a mixture of CLA isomers reduced the expression of the S14 and fatty acid synthase (FAS) genes. The mixture caused a dose-related inhibition of T47D cell growth, as did pure c9, t11 and t10, c12-CLA, but not linoleic acid. Similar effects were observed in MDA-MB-231 breast cancer cells. Provision of 8 mircoM palmitate fully (CLA mix, t10, c12-CLA) or partially (c9, t11-CLA) reversed the antiproliferative effect in T47D cells. CLA likewise suppressed levels of S14 and FAS mRNAs in liposarcoma cells and caused growth inhibition that was prevented by palmitic acid. CLA did not affect the growth of nonlipogenic HeLa cells or human fibroblasts. We conclude that as in bovine mammary and mouse adipose cells, CLA suppresses S14 and FAS gene expression in human breast cancer and liposarcoma cells. Rescue from the antiproliferative effect of CLA by palmitic acid indicates that reduced tumor lipogenesis is a major mechanism for the anticancer effects of CLA.

Citing Articles

Metabolic Reprogramming and Adaption in Breast Cancer Progression and Metastasis.

Zuo Q, Kang Y Adv Exp Med Biol. 2025; 1464():347-370.

PMID: 39821033 DOI: 10.1007/978-3-031-70875-6_17.

Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis.

Kaur R, Gupta S, Kulshrestha S, Khandelwal V, Pandey S, Kumar A Cells. 2025; 14(1.

PMID: 39791706 PMC: 11720085. DOI: 10.3390/cells14010005.

Effects of essential oil of Origanum onites and its major component carvacrol on the expression of toxicity pathway genes in HepG2 cells.

Tomsuk O, Kuete V, Sivas H, Kurkcuoglu M BMC Complement Med Ther. 2024; 24(1):265.

PMID: 38992651 PMC: 11238398. DOI: 10.1186/s12906-024-04571-6.

The role of cancer cell bioenergetics in dormancy and drug resistance.

Tau S, Miller T Cancer Metastasis Rev. 2023; 42(1):87-98.

PMID: 36696004 PMC: 10233409. DOI: 10.1007/s10555-023-10081-7.

Epigallocatechin gallate triggers apoptosis by suppressing de novo lipogenesis in colorectal carcinoma cells.

Khiewkamrop P, Surangkul D, Srikummool M, Richert L, Pekthong D, Parhira S FEBS Open Bio. 2022; 12(5):937-958.

PMID: 35243817 PMC: 9063442. DOI: 10.1002/2211-5463.13391.

References

Belury M . Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J Nutr. 2002; 132(10):2995-8. DOI: 10.1093/jn/131.10.2995. View

Menendez J, Vellon L, Lupu R . Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene. Ann Oncol. 2005; 16(8):1253-67. DOI: 10.1093/annonc/mdi239. View

Ip C, Singh M, Thompson H, Scimeca J . Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res. 1994; 54(5):1212-5. View

Wells W, Schwartz G, Morganelli P, Cole B, Gibson J, Kinlaw W . Expression of "Spot 14" (THRSP) predicts disease free survival in invasive breast cancer: immunohistochemical analysis of a new molecular marker. Breast Cancer Res Treat. 2006; 98(2):231-40. DOI: 10.1007/s10549-005-9154-z. View

Martel P, Bingham C, McGraw C, Baker C, Morganelli P, Meng M . S14 protein in breast cancer cells: direct evidence of regulation by SREBP-1c, superinduction with progestin, and effects on cell growth. Exp Cell Res. 2005; 312(3):278-88. DOI: 10.1016/j.yexcr.2005.10.022. View

House R, Cassady J, Eisen E, Eling T, Collins J, Grissom S . Functional genomic characterization of delipidation elicited by trans-10, cis-12-conjugated linoleic acid (t10c12-CLA) in a polygenic obese line of mice. Physiol Genomics. 2005; 21(3):351-61. DOI: 10.1152/physiolgenomics.00244.2004. View

Harvatine K, Bauman D . SREBP1 and thyroid hormone responsive spot 14 (S14) are involved in the regulation of bovine mammary lipid synthesis during diet-induced milk fat depression and treatment with CLA. J Nutr. 2006; 136(10):2468-74. DOI: 10.1093/jn/136.10.2468. View

Durgam V, Fernandes G . The growth inhibitory effect of conjugated linoleic acid on MCF-7 cells is related to estrogen response system. Cancer Lett. 1997; 116(2):121-30. DOI: 10.1016/s0304-3835(97)00192-4. View

CAILLEAU R, Olive M, Cruciger Q . Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro. 1978; 14(11):911-5. DOI: 10.1007/BF02616120. View

10.

Oskouian B . Overexpression of fatty acid synthase in SKBR3 breast cancer cell line is mediated via a transcriptional mechanism. Cancer Lett. 2000; 149(1-2):43-51. DOI: 10.1016/s0304-3835(99)00342-0. View

11.

Hatzivassiliou G, Zhao F, Bauer D, Andreadis C, Shaw A, Dhanak D . ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell. 2005; 8(4):311-21. DOI: 10.1016/j.ccr.2005.09.008. View

12.

Gaullier J, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H . Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr. 2005; 135(4):778-84. DOI: 10.1093/jn/135.4.778. View

13.

Chajes V, Cambot M, Moreau K, Lenoir G, Joulin V . Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival. Cancer Res. 2006; 66(10):5287-94. DOI: 10.1158/0008-5472.CAN-05-1489. View

14.

Thupari J, Pinn M, Kuhajda F . Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity. Biochem Biophys Res Commun. 2001; 285(2):217-23. DOI: 10.1006/bbrc.2001.5146. View

15.

Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G . Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem. 2006; 17(12):789-810. DOI: 10.1016/j.jnutbio.2006.02.009. View

16.

Ip M, Shoemaker S, Ip C . Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp Cell Res. 1999; 250(1):22-34. DOI: 10.1006/excr.1999.4499. View

17.

Bauman D, Griinari J . Nutritional regulation of milk fat synthesis. Annu Rev Nutr. 2003; 23:203-27. DOI: 10.1146/annurev.nutr.23.011702.073408. View

18.

Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65(1-2):55-63. DOI: 10.1016/0022-1759(83)90303-4. View

19.

Hollywood D, Hurst H . A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines. EMBO J. 1993; 12(6):2369-75. PMC: 413467. DOI: 10.1002/j.1460-2075.1993.tb05891.x. View

20.

Cunningham B, Moncur J, Huntington J, KINLAW W . "Spot 14" protein: a metabolic integrator in normal and neoplastic cells. Thyroid. 1998; 8(9):815-25. DOI: 10.1089/thy.1998.8.815. View